drugset / Trial / NCT00451490

The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder

NCT00451490

Withdrawn 24 enrolled National Taiwan University Hospital
RandomizedParallel-groupDouble-blindHealth-services research

Summary

Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will increase HRV at the end of the treatment.

Timeline

Start
2006-10
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Agomelatine Small molecule
Subject Fluoxentine Unknown